On June 3, Gelonhui reported that Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of May 31, 2024, the company repurchased 5,367,031 shares through a repurchase special securities account in a centralized bidding manner, accounting for 2.31% of the company's total equity; The highest fill price for repurchased shares was 20.98 yuan/share, the lowest fill price was 18.60 yuan/share, and the total transaction amount was RMB 107,570,789.13 (excluding transaction taxes and fees).
明德生物(002932.SZ)：已累计回购2.31%股份
Wuhan Easy Diagnosis Biomedicine (002932.SZ) has cumulatively repurchased 2.31% of its shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.